How APOE affects brain recovery after traumatic brain injury
The Role of ApoE in Injury-Induced Neurogenesis
This work looks at how different forms of the APOE gene change the brain's ability to repair itself and remember things after a traumatic brain injury.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11127697 on NIH RePORTER |
What this research studies
You should know this research focuses on the hippocampus, a memory area of the brain, and how it makes new nerve cells after injury. The team uses genetically modified mice that carry human forms of the APOE gene, including the APOE4 version linked to worse outcomes, to see how those genes change recovery. They map memory-related brain circuits after injury and test whether APOE4 acts as a harmful (dominant negative) driver of poor recovery. The goal is to trace the cellular and circuit mechanisms that control injury-induced neurogenesis so future therapies can target them.
Who could benefit from this research
Good fit: Adults who have experienced a traumatic brain injury, especially those with ongoing memory problems or known APOE-e4 status, would be most relevant to this work.
Not a fit: People without past brain injury, children under 21, or those without interest in genetic links to recovery are unlikely to gain direct benefit from this project.
Why it matters
Potential benefit: If successful, the findings could point to new ways to protect or boost memory recovery after brain injury and help tailor treatments for people with APOE4.
How similar studies have performed: Prior animal and clinical observations link APOE, particularly APOE4, to poorer recovery and to changes in hippocampal neurogenesis, but using a conditional humanized-APOE4 mouse to prove a dominant-negative effect is a newer, more targeted approach.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Kernie, Steven Gerard — Columbia University Health Sciences
- Study coordinator: Kernie, Steven Gerard
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.